Afatinib: emerging next-generation tyrosine kinase inhibitor for NSCLC

Overview of attention for article published in OncoTargets and therapy, March 2013

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 98 Dimensions

Readers on

mendeley: 125 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 3,354 followers.

#Afatinib: emerging #NextGeneration #tyrosine #kinase #inhibitor for #NSCLC: http://t.co/MmwpYEYfxn

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.